BigSur Wealth Management LLC Sells 12,000 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

BigSur Wealth Management LLC decreased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 37.5% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 19,982 shares of the company's stock after selling 12,000 shares during the period. BigSur Wealth Management LLC owned approximately 0.07% of Establishment Labs worth $815,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in ESTA. Quarry LP purchased a new stake in shares of Establishment Labs during the fourth quarter worth about $27,000. Federated Hermes Inc. raised its position in Establishment Labs by 3.0% during the 4th quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after purchasing an additional 953 shares during the last quarter. Swiss National Bank lifted its holdings in Establishment Labs by 2.7% in the 4th quarter. Swiss National Bank now owns 38,500 shares of the company's stock worth $1,774,000 after buying an additional 1,000 shares during the period. Handelsbanken Fonder AB grew its position in shares of Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the last quarter. Finally, KLP Kapitalforvaltning AS bought a new stake in shares of Establishment Labs in the 4th quarter worth approximately $161,000. Institutional investors own 72.91% of the company's stock.

Establishment Labs Stock Up 0.9%

Shares of Establishment Labs stock traded up $0.32 during trading on Friday, hitting $37.44. The company's stock had a trading volume of 659,994 shares, compared to its average volume of 476,529. Establishment Labs Holdings Inc. has a 52 week low of $26.56 and a 52 week high of $52.41. The company has a market capitalization of $1.08 billion, a PE ratio of -14.51 and a beta of 0.74. The company has a fifty day simple moving average of $33.99 and a two-hundred day simple moving average of $37.36. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.83) by $0.13. The firm had revenue of $41.38 million during the quarter, compared to analyst estimates of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The business's revenue was up 11.3% on a year-over-year basis. During the same period last year, the business earned ($0.58) earnings per share. Equities research analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on ESTA. Needham & Company LLC restated a "buy" rating and set a $48.00 target price on shares of Establishment Labs in a report on Friday. BTIG Research started coverage on shares of Establishment Labs in a research note on Friday, May 16th. They set a "buy" rating and a $62.00 target price on the stock. Stephens reissued an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a research note on Thursday, March 6th. Finally, Wall Street Zen upgraded shares of Establishment Labs from a "sell" rating to a "hold" rating in a report on Saturday. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $52.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.